LSBCF (LakeShore Biopharma Co) Total Equity: $68.94 Mil (As of Mar. 2025)


What is LakeShore Biopharma Co Total Equity?

LakeShore Biopharma Co LSBCF Total Equity is $68.94 Mil as of Mar. 2025. The stock has 5 warning signs investors should review.

LakeShore Biopharma Co's total equity for the quarter that ended in Mar. 2025 was $68.94 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

LakeShore Biopharma Co Total Equity Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Total Equity Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Total Equity
-78.16 -110.17 105.71 81.26 68.94

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Total Equity Get a 7-Day Free Trial Premium Member Only 105.71 76.34 81.26 85.15 68.94

LakeShore Biopharma Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

LakeShore Biopharma Co's Total Equity for the fiscal year that ended in Mar. 2025 is calculated as

Total Equity=Total Assets(Q: Mar. 2025 )-Total Liabilities(Q: Mar. 2025 )
=188.661-119.723
=68.94

LakeShore Biopharma Co's Total Equity for the quarter that ended in Mar. 2025 is calculated as

Total Equity=Total Assets(Q: Mar. 2025 )-Total Liabilities(Q: Mar. 2025 )
=188.661-119.723
=68.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $68.94 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Total Equity of $68.94 Mil as of Mar. 2025. The total amount of equity as record on a company's balance sheet. View historical data for LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Total Equity too high?
LakeShore Biopharma Co's current Total Equity is $68.94 Mil.
How does LakeShore Biopharma Co's Total Equity compare to ACUT and PPCB?
LakeShore Biopharma Co's Total Equity of $68.94 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Total Equity is $68.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Total Equity of $68.94 Mil. The current Total Equity is $68.94 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Total Equity is $68.94 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.